PA8515601A1 - El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos - Google Patents

El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos

Info

Publication number
PA8515601A1
PA8515601A1 PA20018515601A PA8515601A PA8515601A1 PA 8515601 A1 PA8515601 A1 PA 8515601A1 PA 20018515601 A PA20018515601 A PA 20018515601A PA 8515601 A PA8515601 A PA 8515601A PA 8515601 A1 PA8515601 A1 PA 8515601A1
Authority
PA
Panama
Prior art keywords
mammals
protozoary
treat
antibiotics
bacterial
Prior art date
Application number
PA20018515601A
Other languages
English (en)
Inventor
Wayne Alan Boettner
Peter Connor Canning
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8515601A1 publication Critical patent/PA8515601A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBEN MÉTODOS PARA TRATAR O PREVENIR INFECCIONES BACTERIANAS O PROTOZOARIAS EN MAMÍFEROS POR ADMINISTRACIÓN DE UNA ÚNICA DOSIS DE UNA COMPOSICIÓN DE ANTIBIÓTICOS QUE COMPRENDE UNA MEZCLA DE ISÓMEROS DE AZALIDOS Y UN VEHÍCULO FARMACEUTICAMENTE ACEPTABLE. SE DESCRIBEN TAMBIÉN MÉTODOS PARA AUMENTAR LA TOLERANCIA DE SITIOS DE INYECCIÓN, AGUDA O CRÓNICA, EN MAMÍFEROS POR ADMINISTRACIÓN DE UNA ÚNICA DOSIS DE COMPOSICIONES ANTIBIÓTICAS QUE COMPRENDE UNA MEZCLA DE ISÓMEROS AZALIDOS Y UN VEHÍCULO FARMACÉUTICAMENTE ACEPTABLE. SE DESCRIBE TAMBIÉN UNA COMBINACIÓN QUE COMPRENDE: UNA COMPOSICI ANTIBIÓTICA QUE COMPRENDE UNA MEZCLA DE ISÓMEROS DE AZALIDOS, UN VEHÌCULO FARMACÉUTICAMENTE ACEPTABLE, E INSTRUCCIONES PARA EL USO EN UNA ADMINISTRACIÓN DE UNA SOLA DOSIS.
PA20018515601A 2000-04-27 2001-04-17 El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos PA8515601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19996100P 2000-04-27 2000-04-27

Publications (1)

Publication Number Publication Date
PA8515601A1 true PA8515601A1 (es) 2002-07-30

Family

ID=22739732

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018515601A PA8515601A1 (es) 2000-04-27 2001-04-17 El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos

Country Status (30)

Country Link
US (2) US20020019353A1 (es)
EP (1) EP1276747A1 (es)
JP (1) JP2004516233A (es)
KR (1) KR20030031479A (es)
CN (1) CN1227258C (es)
AP (1) AP2002002652A0 (es)
AR (1) AR028041A1 (es)
AU (1) AU4269301A (es)
BG (1) BG107168A (es)
BR (1) BR0110382A (es)
CA (1) CA2407448A1 (es)
CZ (1) CZ20023409A3 (es)
EA (1) EA200200995A1 (es)
GT (1) GT200100063A (es)
HU (1) HUP0300585A3 (es)
IL (1) IL152421A0 (es)
IS (1) IS6559A (es)
MA (1) MA26896A1 (es)
MX (1) MXPA02010586A (es)
NO (1) NO20025134L (es)
OA (1) OA12257A (es)
PA (1) PA8515601A1 (es)
PE (1) PE20011188A1 (es)
PL (1) PL359861A1 (es)
SK (1) SK14882002A3 (es)
TN (1) TNSN01063A1 (es)
UY (1) UY26678A1 (es)
WO (1) WO2001081358A1 (es)
YU (1) YU78702A (es)
ZA (1) ZA200208603B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2009006466A1 (en) * 2007-07-02 2009-01-08 Novus International Inc. Feeding regime for prevention of porcine enteropathic conditions
US8314071B2 (en) 2007-12-21 2012-11-20 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
US10568923B2 (en) * 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
EP2866794A4 (en) * 2012-06-27 2015-12-09 Kemin Ind Inc PARTS AND PLANT EXTRACTS WITH ANTICOCCIDIAN ACTIVITY
CN109414037A (zh) 2016-12-15 2019-03-01 雀巢产品技术援助有限公司 调节伴侣动物中的细菌的组合物和方法
CN106905395A (zh) * 2017-02-21 2017-06-30 西南大学 丁二酸替米考星复盐的制备方法
CN106905396A (zh) * 2017-02-21 2017-06-30 西南大学 富马酸替米考星复盐的制备方法
CN106749458A (zh) * 2017-02-21 2017-05-31 西南大学 苹果酸替米考星复盐的制备方法
JP7100652B2 (ja) * 2017-02-22 2022-07-13 アイエスアール イミューン システム レギュレイション ホールディング アクチエボラグ(パブル) 新規免疫刺激マクロライド
KR20210133950A (ko) * 2018-11-19 2021-11-08 지카니 테라퓨틱스, 인크. C10-알킬렌 치환된 13-원 매크롤라이드 및 이의 용도
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法
KR20240056746A (ko) * 2021-09-07 2024-04-30 조에티스 서비시즈 엘엘씨 면역조정성 아잘라이드

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
ZA200208603B (en) 2003-10-24
WO2001081358A1 (en) 2001-11-01
NO20025134L (no) 2002-12-19
HUP0300585A3 (en) 2003-09-29
UY26678A1 (es) 2001-12-28
US20040235759A1 (en) 2004-11-25
AU4269301A (en) 2001-11-07
GT200100063A (es) 2002-02-18
IL152421A0 (en) 2003-05-29
CZ20023409A3 (cs) 2004-01-14
SK14882002A3 (en) 2004-11-03
PE20011188A1 (es) 2001-11-24
US20020019353A1 (en) 2002-02-14
AR028041A1 (es) 2003-04-23
HUP0300585A2 (hu) 2003-06-28
JP2004516233A (ja) 2004-06-03
CN1429232A (zh) 2003-07-09
IS6559A (is) 2002-09-20
CA2407448A1 (en) 2001-11-01
EA200200995A1 (ru) 2003-04-24
MXPA02010586A (es) 2003-03-10
OA12257A (en) 2003-11-06
TNSN01063A1 (fr) 2005-11-10
AP2002002652A0 (en) 2002-12-31
NO20025134D0 (no) 2002-10-25
BR0110382A (pt) 2003-06-24
KR20030031479A (ko) 2003-04-21
PL359861A1 (en) 2004-09-06
CN1227258C (zh) 2005-11-16
BG107168A (bg) 2003-07-31
MA26896A1 (fr) 2004-12-20
YU78702A (sh) 2005-11-28
EP1276747A1 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
PA8515601A1 (es) El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos
NO20002851L (no) Blandinger for nasal administrasjon av medikamenter
BRPI0518282A2 (pt) uso de uma quantidade terapeuticamente ou profilaticamente efetiva de um composto imunomodulatàrio
CO5700796A2 (es) Composiciones que contienen piperacilina y tazobactam utiles para inyecciones
BR0112311A (pt) Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso
AR034746A1 (es) Combinaciones para el tratamiento de trastornos inflamatorios
ES2117015T3 (es) Composiciones que contienen sumatriptan.
NO20100302L (no) Sammensetninger som inneholder organiske forbindelser
ECSP003847A (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
AR067347A1 (es) Combinacion antihelmintica
CO5680108A1 (es) Compuestos para el tratamiento de la disfuncion sexual femenina
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
NO20000314D0 (no) Farmasoeytiske sammensetninger som inneholder lysostafin alene eller i kombinasjon med et antibiotika for behandling av stafylokokkinfeksjoner
ES2129078T3 (es) Preparacion farmaceutica que comprende un compuesto capaz de degradar los antibioticos beta-lactamicos y su utilizacion.
FI964285A (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
AR012217A1 (es) Una composicion topica para mejorar la penetracion de compuestos farmaceuticos
BR0112847A (pt) Uso de uma forma de dosagem sólida
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
EA200701542A1 (ru) Антигельминтная композиция
ATE378070T1 (de) Zusammensetzung mit fulvestrant
AR056517A1 (es) Composiciones y metodos farmaceuticos utilizando temozolomida y un inhibidor de la proteina quinasa
CL2004000765A1 (es) Composicion farmaceutica intranasal que comprende un compuesto derivado de 8,9-dioxo-2,6-diazabiciclo.